Financing for growth companies within life science
What we offer
Sciety provides the entire project management of the process from production of presentation material to the funds arriving in your account. We initiate cooperation by identifying your requirements and establishing a time plan. Based on our specialist competence in life science and a structured approach, we contribute with an in-depth understanding of your operations, as well as expertise in the most efficient means of achieving your goals. Sciety assists in producing investment material, communication with investors and the administration of the investments.
Focus on promising companies
Sciety focuses on prominent companies within biotechnology, digital health, pharmacology, ICT in healthcare and medical technology seeking to raise MSEK 10-100. The companies’ development phase depends on the area and innovation level. Pharmaceutical companies should be in the late preclinical phase or early clinical phase, while companies within digital health should have an initial user base. Sciety has a structured process for selecting and reviewing companies in which business potential and medical and legal aspects are analysed.
What our clients think
Communication with the capital markets
What we offer
Sciety works proactively in communicating about the company to potential investors and to strengthen their relationships with existing shareholders. Based on our experience within life science and digital communication, we transform complex information to effective communication. Included in our communication package are, amongst other things, the design and distribution of press releases, communication in social media and digital channels, build up of the home web page and implementation of analysis tools.
Is this for you
In the growth phase the core operations often receive all of the focus and it can be difficult to find time for communication. At the same time, relevant and continual communication is something which investors value notably. Our communications package is aimed at companies wishing to build up long-term relationships in the capital market in order to facilitate future capital acquisition. These services are appropriate for small and medium-sized companies within life science where there is a need of external capital within a three-year period.
What our clients think
“Sciety took care of all communication in conjunction with securing capital for our company. Their understanding of life science and finance made it possible for us to produce relevant and clear content in press releases and similar communication.
Through Sciety’s channels, we received market exposure in, amongst other places, Dagens Industri’s web page, something that was very valuable”.
Carina Schmidt, CEO at Athera Biotechnologies